157 related articles for article (PubMed ID: 29801972)
21. Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.
Rocha V; Porcher R; Fernandes JF; Filion A; Bittencourt H; Silva W; Vilela G; Zanette DL; Ferry C; Larghero J; Devergie A; Ribaud P; Skvortsova Y; Tamouza R; Gluckman E; Socie G; Zago MA
Leukemia; 2009 Mar; 23(3):545-56. PubMed ID: 19005482
[TBL] [Abstract][Full Text] [Related]
22. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Viel DO; Tsuneto LT; Sossai CR; Lieber SR; Marques SB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA; Visentainer JE
Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
[TBL] [Abstract][Full Text] [Related]
23. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Cavet J; Dickinson AM; Norden J; Taylor PR; Jackson GH; Middleton PG
Blood; 2001 Sep; 98(5):1594-600. PubMed ID: 11520812
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population.
Xiao H; Cao W; Lai X; Luo Y; Shi J; Tan Y; He J; Xie W; Meng X; Zheng W; Zheng G; Han X; Jin L; Zhang L; Wang Y; Yu X; Cai Z; Lin M; Ye X; Huang H
Biol Blood Marrow Transplant; 2011 Apr; 17(4):542-9. PubMed ID: 20457266
[TBL] [Abstract][Full Text] [Related]
25. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
[TBL] [Abstract][Full Text] [Related]
26. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
27. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.
Lin MT; Storer B; Martin PJ; Tseng LH; Gooley T; Chen PJ; Hansen JA
N Engl J Med; 2003 Dec; 349(23):2201-10. PubMed ID: 14657427
[TBL] [Abstract][Full Text] [Related]
28. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation.
Bertinetto FE; Dall'Omo AM; Mazzola GA; Rendine S; Berrino M; Bertola L; Magistroni P; Caropreso P; Falda M; Locatelli F; Busca A; Amoroso A
Int J Immunogenet; 2006 Oct; 33(5):375-84. PubMed ID: 16984283
[TBL] [Abstract][Full Text] [Related]
29. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.
Santos N; Rodríguez-Romanos R; de la Cámara R; Brunet S; Nieto JB; Buño I; Martínez C; Jiménez-Velasco A; Vallejo C; González M; Solano C; Ferrá C; Sampol A; Pérez-Simón JA; López-Jiménez J; Díez JL; Gallardo D;
Ann Hematol; 2018 Nov; 97(11):2217-2224. PubMed ID: 30019128
[TBL] [Abstract][Full Text] [Related]
30. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.
Lin MT; Storer B; Martin PJ; Tseng LH; Grogan B; Chen PJ; Zhao LP; Hansen JA
Blood; 2005 Dec; 106(12):3995-4001. PubMed ID: 16109775
[TBL] [Abstract][Full Text] [Related]
32. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
Hosseini E; Schwarer AP; Ghasemzadeh M
Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
[TBL] [Abstract][Full Text] [Related]
33. Cytokine gene polymorphisms in kidney transplantation.
Dhaouadi T; Sfar I; Bardi R; Jendoubi-Ayed S; Abdallah TB; Ayed K; Gorgi Y
Transplant Proc; 2013; 45(6):2152-7. PubMed ID: 23747182
[TBL] [Abstract][Full Text] [Related]
34. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
[TBL] [Abstract][Full Text] [Related]
35. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
[TBL] [Abstract][Full Text] [Related]
36. Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced disease.
Gómez-Almaguer D; Gómez-Peña Á; Jaime-Pérez JC; Gómez-Guijosa MÁ; Cantú-Rodríguez O; Gutiérrez-Aguirre H; Martínez-Cabriales SA; García-Rodríguez F; Olguín-Ramírez LA; Salazar-Riojas R; Méndez-Ramírez N
J Clin Apher; 2013 Oct; 28(5):349-55. PubMed ID: 23682006
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
38. The effects of gene polymorphisms on susceptibility to acute GVHD and survival of allogeneic HSCT recipients: IL-10 gene polymorphisms as a more accessible target to predict prognosis.
Granero Farias M; Andrade Dos Santos C; de Mello Vicente B; Habigzang M; de Oliveira da Silva P; Emerim Lemos N; Dieter C; Paz A; Esteves Daudt L
Hum Immunol; 2020 Jan; 81(1):18-25. PubMed ID: 31889553
[TBL] [Abstract][Full Text] [Related]
39. Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease.
Resende RG; Correia-Silva JD; Silva TA; Xavier SG; Bittencourt H; Gomez RS; Abreu MH
Oral Dis; 2012 Nov; 18(8):816-22. PubMed ID: 22748084
[TBL] [Abstract][Full Text] [Related]
40. Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation.
Cardozo DM; Lieber SR; Marques SB; Aranha FJ; Vigorito AC; Souza CA; Visentainer JE
Sao Paulo Med J; 2012; 130(4):219-24. PubMed ID: 22965361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
